U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06943937) titled 'An Clinical Study of YTS109 Cell Injection in Subjects With Refractory Systemic Lupus Erythematosus' on April 16.
Brief Summary: An Exploratory Clinical Study of YTS109 Cell Injection in Subjects With Refractory Systemic Lupus Erythematosus.
Study Start Date: April 25
Study Type: INTERVENTIONAL
Condition:
Systemic Lupus Erythematosus
Thrombocytopenia
Intervention:
DRUG: YTS109 cell injection
Subjects will receive YTS109 Cell Injection(1E6 STAR+T cell/kg or 2E6 STAR+T cell/kg) once in this study.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Published by HT Digital Conte...